A robust CD8<sup>+</sup> T cell-related classifier for predicting the prognosis and efficacy of immunotherapy in stage III lung adenocarcinoma.

Front Immunol · 2022 · PMC9471021 · PMID 36119068

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a negative trendno p-value reported

For the expression of HDFRP3, unfortunately, we only got a negative trend with CD8 (r = -0.2559), but without significant statistical significance, probably due to the small sample size.

also in 4,201 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.